Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Fibrillarin Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5102361
Description
Antibody detects endogenous levels of total FBL.
Nop1p / Fibrillarin was originally identified as a nucleolar protein of bakers yeast, Saccharomyces cerevisiae (accession P15646). The Nop1p protein is essential for yeast viability and is localized in the nucleoli. The human homologue of Nop1p is fibrillarin (accession P22087) a component of the nucleolar small nuclear ribonucleoprotein (snRNP) particle. The human fibrillarin gene is located on chromosome 19 (19q13. 1).
Specifications
Fibrillarin | |
Polyclonal | |
Unconjugated | |
fbl | |
34 kDa nucleolar scleroderma antigen; 34-kD nucleolar scleroderma antigen; AL022665; AT20009p; CELE_T01C3.7; CG5725; CG5725-PA; CG5725-PB; CG5725-PC; CG5725-PD; CG5725-PE; CG5725-PF; CG5725-PG; Dmel\CG5725; Dmel_CG5725; dPANK; dPANK/Fbl; Fbl; fbl-PA; fbl-PB; fbl-PC; fbl-PD; fbl-PE; fbl-PF; fbl-PG; FIB; FIB1; fib-1; fibrillarin; FLRN; fumble; histone-glutamine methyltransferase; LD24618p; LP11571p; nucleolar protein 1; PANK; pantothenate kinase; RNA, U3 small nucleolar interacting protein 1; RNU3IP1; rRNA 2'-O-methyltransferase fibrillarin; T01C3.7 | |
Rabbit | |
Affinity Chromatography | |
RUO | |
14113, 2091, 292747 | |
-20°C | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
1 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
P22087, P22509, P35550 | |
fbl | |
A synthesized peptide derived from human FBL(Accession P22087), corresponding to amino acid residues V107-I157. | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction